ROSSI, Silvia
 Distribuzione geografica
Continente #
NA - Nord America 496
EU - Europa 335
AS - Asia 237
Totale 1.068
Nazione #
US - Stati Uniti d'America 494
CN - Cina 151
IE - Irlanda 94
SE - Svezia 69
FI - Finlandia 62
SG - Singapore 55
IT - Italia 46
DE - Germania 37
TR - Turchia 26
UA - Ucraina 8
CZ - Repubblica Ceca 5
BE - Belgio 3
FR - Francia 3
GB - Regno Unito 3
JP - Giappone 2
AL - Albania 1
AZ - Azerbaigian 1
CA - Canada 1
EE - Estonia 1
ES - Italia 1
IL - Israele 1
IR - Iran 1
NL - Olanda 1
PA - Panama 1
RU - Federazione Russa 1
Totale 1.068
Città #
Chandler 124
Dublin 94
Singapore 50
Santa Clara 49
Ashburn 33
Dearborn 29
Beijing 27
Izmir 26
Parma 25
Nanjing 24
Ann Arbor 23
Jacksonville 23
Boardman 18
Wilmington 16
Princeton 15
Shanghai 15
Munich 11
San Mateo 9
Shenyang 9
Jinan 8
Tianjin 8
Hangzhou 6
Helsinki 6
Kunming 6
Nanchang 6
Bremen 5
Brno 5
Hefei 5
Changsha 4
Cornaredo 4
Düsseldorf 4
New York 4
Taiyuan 4
Zhengzhou 4
Brescia 3
Brussels 3
Hebei 3
Jiaxing 3
Cagliari 2
Dallas 2
Des Moines 2
Frankfurt am Main 2
Fremont 2
Fuzhou 2
Haikou 2
Houston 2
Mountain View 2
Taizhou 2
Tokyo 2
Atlanta 1
Baku 1
Baoding 1
Bologna 1
Cassino 1
Collecchio 1
Edinburgh 1
Falls Church 1
Grafing 1
Guangzhou 1
Huizen 1
London 1
Los Angeles 1
Marseille 1
Ningbo 1
Orland Park 1
Ottawa 1
Padova 1
Panama City 1
Redwood City 1
Sandston 1
Seattle 1
Segrate 1
Stockholm 1
Tallinn 1
Tel Aviv 1
Tirana 1
Washington 1
Wenzhou 1
Zanjan 1
Totale 763
Nome #
Antithetic glypican control of cancer growth and dissemination 117
Prognostic modeling of oral cancer by gene profiles and clinicopathological co-variables 102
Proteoglycans in metastasis formation and anti-neoplastic therapeutic approaches 93
The NeoMark Project interim results: integration of heterogeneous data for prediction of oral squamous cell cancer (OSCC) recurrence. 81
Development of a multiomics database for personalized prognostic forecasting in head and neck cancer: The Big Data to Decide EU Project 71
Integration of clinical, histopathological, radiological and biomolecular data for prediction of oral squamous cell cancer (OSCC) recurrence: the NeoMark Project’s first report. 71
Proteoglycans as potential markers of the biological behaviour of head and neck carcinomas: Interim Results of a Multicenter Italian Project. 65
Integration of clinical, histopathological, radiological and biomolecular data for prediction of oral cancer recurrence: the NeoMark Project’s first report. 65
Antithetic roles of proteoglycans in cancer 64
Proteoglycans as Potential Markers of the Biological Behaviour of Head and Neck Carcinomas: Interim Results of a Multicenter Italian Project. 62
Evaluation of immunohistochemical and biomolecular parameters as markers of the biological behaviour of head and neck carcinomas: preliminary results of a multicenter Italian Project. 59
Proteoglycan-based diversification of disease outcome in head and neck cancer patients identifies NG2/CSPG4 and syndecan-2 as unique relapse and overall survival predicting factors 59
Glypican and Syndecan: tumor growth regulators 58
Modulation of sarcomacell movement and matrix interaction following manipulation of cell surface proteoglycans 56
Risk stratification and prediction of locoregional recurrence in patients affected by oral squamous cell carcinoma (OSCC): the NeoMark project results. 55
Totale 1.078
Categoria #
all - tutte 4.108
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.108


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202077 0 0 0 0 0 0 25 5 11 25 2 9
2020/202165 2 2 4 4 8 1 4 3 30 1 5 1
2021/202284 2 3 17 2 1 2 3 16 5 5 9 19
2022/2023356 28 51 16 34 24 41 1 34 115 0 10 2
2023/2024110 8 13 6 0 12 25 0 6 11 2 3 24
2024/2025142 3 18 15 15 52 39 0 0 0 0 0 0
Totale 1.078